XML 83 R57.htm IDEA: XBRL DOCUMENT v3.25.0.1
Loan and Security Agreements - Additional Information (Details) - USD ($)
12 Months Ended
Dec. 20, 2024
Nov. 20, 2024
Sep. 26, 2024
Sep. 09, 2022
Dec. 31, 2024
Dec. 31, 2023
Debt Instrument [Line Items]            
Debt instrument drew         $ 32,500,000  
Rcognized loss from extinguishment         $ (1,090,000)  
K2HV [Member]            
Debt Instrument [Line Items]            
Principal amount       $ 60,000,000    
Facility fee       $ 400,000    
Additional principal amount percentage       1.00%    
Term loan maturity date       Sep. 01, 2026    
Interest only payment term       24 months    
Interest only payment extended term     12 months 36 months    
Contractual interest rate       8.75%    
Prime rate       4.75%    
Interest rate       9.90% 12.61%  
Conversion price   $ 4.785   $ 4.785    
Repaid remaining principal amount $ 15,000,000          
Exit fee 1,800,000          
Prepayment fee 300,000          
Rcognized loss from extinguishment (1,100,000)          
Final fee       6.00%    
Convertible outstanding principal balance   $ 15,000,000        
Converted instrument, shares issued   3,134,796        
Interest expense         $ 3,600,000 $ 3,800,000
Silicon Valley Bank [Member]            
Debt Instrument [Line Items]            
Principal amount $ 52,500,000          
Term loan maturity date Sep. 01, 2029          
Contractual interest rate 7.00%          
Prime rate 0.75%          
Interest rate         8.46%  
Final fee 5.00%          
Percentage of loan prepayment fee in first year 3.00%          
Percentage of loan prepayment fee in year two 2.00%          
Percentage of loan prepayment fee in there after year two 1.00%          
Debt instrument payment, description         The term loans will mature on September 1, 2029, and will be subject to monthly interest only payments until September 30, 2027, provided the Company achieves certain financial and clinical milestones, following which the term loans will amortize in equal monthly installments until maturity. If the Company does not achieve such financial and clinical milestones by June 30, 2026, the maturity date will be September 1, 2028, and the interest only period will end on September 30, 2026, following which the term loans will amortize in equal monthly installments until maturity.  
Interest expense         $ 100,000  
Tranche One [Member] | K2HV [Member]            
Debt Instrument [Line Items]            
Debt instrument drew       $ 30,000,000    
Tranche One [Member] | Silicon Valley Bank [Member]            
Debt Instrument [Line Items]            
Debt instrument drew $ 32,500,000          
Tranche Two [Member] | K2HV [Member]            
Debt Instrument [Line Items]            
Debt instrument remaining borrowing capacity       10,000,000    
Tranche Two [Member] | Silicon Valley Bank [Member]            
Debt Instrument [Line Items]            
Debt instrument remaining borrowing capacity $ 20,000,000          
Tranche Three [Member] | K2HV [Member]            
Debt Instrument [Line Items]            
Debt instrument remaining borrowing capacity       $ 20,000,000    
Maximum [Member] | K2HV [Member]            
Debt Instrument [Line Items]            
Prepayment fee range       4.00%    
Maximum [Member] | Silicon Valley Bank [Member]            
Debt Instrument [Line Items]            
Contractual interest rate 9.75%          
Minimum [Member] | K2HV [Member]            
Debt Instrument [Line Items]            
Prepayment fee range       1.00%